Cannabis use in epilepsy. current situation in argentina and abroad

Authors

  • Silvia Kochen Silvia Kochen Jefa Sección de Epilepsia, División Neurología, Hospital “Ramos Mejía” Profesora de Neurología, Facultad de Medicina, UBA Investigadora CONICET Directora de la Unidad Ejecutora de Estudios en Neurociencias y Sistemas Complejos (ENYS), CONICET - Hospital El Cruce Néstor Kirchner - Universidad Nacional A. Jauretche

Keywords:

Cannabis, Epilepsy, Treatment, Legislation, Clinical Trial

Abstract

Although at present we have over 20 different types of drugs for epilepsy, 30 to 40% of patients continue to have seizures. Preliminary data from human studies suggest that cannabis, cannabidiol in particular, is effective in the treatment of some patients with epilepsy. However, the available data are limited and do not allow definitive conclusions. Only randomized clinical trials with controlled double-blind, placebo-controlled utilizing secure preparations and one or more cannabinoids, will provide
comprehensive information on the efficacy and safety of use. In order to perform these trials it is necessary to have legislation authorizing the use of cannabis on epilepsy. 

Downloads

Download data is not yet available.

Published

2017-01-10

How to Cite

Kochen, S. (2017). Cannabis use in epilepsy. current situation in argentina and abroad. Vertex Revista Argentina De Psiquiatría, 27(130, nov.-dic.), 457–462. Retrieved from https://www.revistavertex.com.ar/ojs/index.php/vertex/article/view/626

Most read articles by the same author(s)